AI device could be cheaper and more accurate than smear tests

UK startup Lancor Scientific has secured funding to launch a medical device that aims to use artificial intelligence (AI) to detect cervical cancer with 90% accuracy and at a lower cost than currently available tests. Conventional smear tests have an accuracy of 60%-70%, but the company hopes its Tumour Trace will produce results that are 90% accurate after securing backing from the Austrian government. Smear tests cost around £30 plus lab processing costs, but Lancor said Tumour Trace will be able to do the same procedure in just two minutes and at £5-£10  per test.
The portability of the device also makes it suitable for use in the developing world. A London-based medtech company, Lancor has already conducted successful trials with the NHS and improved upon the current accuracy of 60%-70% for certain cancer screening tests by pathologists.